The Patent Finder

Shenzhen Hightide Biopharmaceutical, Ltd.

17 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Mar 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 27, 2026
    The maintenance fee for Pharmaceutical Composition Comprising Berberine Salts for the Treatment of Various Diseases or Disorders (US 11,685,735) comes due Dec 27, 2026. Unpaid by Jun 28, 2027, it lapses early.
  • 1 fee due May 7, 2027
    The maintenance fee for Conjugates of islet neogenesis peptides and analogs, and methods thereof (US 11,807,672) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
  • 2 fees due Jul 9 to 30, 2027 · next Jul 9
  • 1 fee due Nov 7, 2027
    The maintenance fee for Pharmaceutical Composition Comprising Berberine and Ursodeoxycholic Acid for the Treatment of Various Diseases or Disorders (US 11,976,063) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,388,215Compositions and methods of using islet neogenesis peptides and analogs thereof
In force
 · USPTO record
In forceUSPTO record
US 9,738,695Compositions and methods of using islet neogenesis peptides and analogs thereof
In force
 · USPTO record
In forceUSPTO record
US 11,559,531Liquid Formulation Compositions, Medicament Delivery Devices, and Methods of Preparation and Use Thereof
In force
 · Medium confidence
In forceMedium confidence
US 11,976,063Pharmaceutical Composition Comprising Berberine and Ursodeoxycholic Acid for the Treatment of Various Diseases or Disorders
In force
 · High confidence
In forceHigh confidence
US 10,988,471Pharmaceutical Composition Comprising Berberine Ursodeoxycholic Acid Salt for the Treatment of Various Diseases or Disorders
In force
 · High confidence
In forceHigh confidence
US 10,301,303Berberine Salts, Ursodeoxycholic Salts and Combinations, Methods of Preparation and Application Thereof
In force
 · High confidence
In forceHigh confidence
US 11,685,735Pharmaceutical Composition Comprising Berberine Salts for the Treatment of Various Diseases or Disorders
In force
 · High confidence
In forceHigh confidence
US 11,369,573Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof
In force
 · USPTO record
In forceUSPTO record
US 11,883,539Pharmaceutical compositions of berberine with EPA and DHA, and methods thereof
In force
 · USPTO record
In forceUSPTO record
US 10,829,527Conjugates of islet neogenesis peptides and analogs, and methods thereof
In force
 · USPTO record
In forceUSPTO record
10 of 17 patents shown.
Pro members see all 17.
Pro members: see all 17 patents
Also on record, not counted in the 17: 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 1 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited